The online version of this article (doi:10.1186/1471-2288-11-102) contains supplementary material, which is available to authorized users.
An erratum to this article is available at http://dx.doi.org/10.1186/s12874-017-0292-x.
The authors declare that they have no competing interests.
KH, JM and AS conceived the idea. KH wrote the first and subsequent drafts. AG and RJL helped developed the ideas. All authors read and approved the final manuscript.
Cluster randomised controlled trials (CRCTs) are frequently used in health service evaluation. Assuming an average cluster size, required sample sizes are readily computed for both binary and continuous outcomes, by estimating a design effect or inflation factor. However, where the number of clusters are fixed in advance, but where it is possible to increase the number of individuals within each cluster, as is frequently the case in health service evaluation, sample size formulae have been less well studied.
We systematically outline sample size formulae (including required number of randomisation units, detectable difference and power) for CRCTs with a fixed number of clusters, to provide a concise summary for both binary and continuous outcomes. Extensions to the case of unequal cluster sizes are provided.
For trials with a fixed number of equal sized clusters (k), the trial will be feasible provided the number of clusters is greater than the product of the number of individuals required under individual randomisation (n I ) and the estimated intra-cluster correlation (ρ). So, a simple rule is that the number of clusters (k) will be sufficient provided:
Where this is not the case, investigators can determine the maximum available power to detect the pre-specified difference, or the minimum detectable difference under the pre-specified value for power.
Designing a CRCT with a fixed number of clusters might mean that the study will not be feasible, leading to the notion of a minimum detectable difference (or a maximum achievable power), irrespective of how many individuals are included within each cluster.
Murray DM: The Design and Analysis of Group-Randomized Trials. 1998, London: Oxford, University Press
Donner A, Klar N: Design and Analysis of Cluster Randomised Trials in Health Research. London: Arnold. 2000
Donner A, Birkett N, Buck C: Randomization by cluster: sample size requirements and analysis. American Journal of Epidemiology. 1981, 114: 906-914. PubMed
MacArthur C, Winter HR, Bick DE, Lilford RJ, Lancashire RJ, Knowles H, et al: Redesigning postnatal care: a randomised controlled trial of protocol-based midwifery-led care focused on individual womens physical and psychological health needs. Health Technology Assessment. 2003, 7: 37- CrossRef
MacArthur C, K KJ, Ingram L, Freemantle N, Dennis CL, Hamburger R, et al: Antenatal peer support workers and breastfeeding initiation: a cluster randomised controlled trial. BMJ. 2009, 338-
Davies MJ, Heller S, Skinner TC, Campbell MJ, Carey ME, Cradock S, et al: Effectiveness of the diabetes education and self management for ongoing and newly diagnosed (DESMOND) programme for people with newly diagnosed type 2 diabetes: cluster randomised controlled trial. BMJ. 2008, 336: 491-495. 10.1136/bmj.39474.922025.BE. CrossRefPubMedPubMedCentral
Avery AJ, Rodgers S, Cantrill JA, Armstrong S, Elliott R, Howard R, et al: Protocol for the PINCER trial: a cluster randomised trial comparing the effectiveness of a pharmacist-led IT-based intervention with simple feedback in reducing rates of clinically important errors in medicines management in general practices. Trials. 2009, 10: 28-10.1186/1745-6215-10-28. CrossRefPubMedPubMedCentral
Armitage P, Berry G, Matthews JNS: Statistical methods in medical research. 2002, London: Blackwell Publishing CrossRef
Edwards SJ, Braunholtz D, Jackson J: Why underpowered trials are not necessarily unethical. Lancet. 2001, 350: 804-807. CrossRef
Medical Research Council: Cluster randomsied trials: methodological and ethical considerations; 2002. [ http://www.mrc.ac.uk]
- Sample size calculations for cluster randomised controlled trials with a fixed number of clusters
Alan J Girling
Alice J Sitch
Richard J Lilford
- BioMed Central
Neu im Fachgebiet AINS
Meistgelesene Bücher aus dem Fachgebiet AINS
Mail Icon II